找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Disease Recurrence After Liver Transplantation; Natural History, Tre Paul J. Thuluvath Book 2016 Springer Science+Business Media New York 2

[復(fù)制鏈接]
樓主: otitis-externa
11#
發(fā)表于 2025-3-23 11:14:35 | 只看該作者
12#
發(fā)表于 2025-3-23 14:28:59 | 只看該作者
13#
發(fā)表于 2025-3-23 19:12:16 | 只看該作者
14#
發(fā)表于 2025-3-23 22:22:50 | 只看該作者
15#
發(fā)表于 2025-3-24 03:28:08 | 只看該作者
Treatment of Recurrent Hepatitis C,e the natural history of recurrent hepatitis. Preliminary studies indicate that approximately 90 % of people with recurrent HCV could be cured with a combination of direct acting antiviral drugs with minimal side effects.
16#
發(fā)表于 2025-3-24 08:52:59 | 只看該作者
17#
發(fā)表于 2025-3-24 12:01:43 | 只看該作者
Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation,s are limited for recurrent PSC. For these important entities affecting PSC patients after liver transplantation, we review the current published data on epidemiology, diagnostic criteria, risk factors, graft and patient survival, and treatment of recurrent PSC.
18#
發(fā)表于 2025-3-24 17:21:01 | 只看該作者
19#
發(fā)表于 2025-3-24 19:51:58 | 只看該作者
Recurrence of HCC When Transplanted Outside Milan Criteria,r LT. The main disadvantage of this set of criteria is that it is relatively restrictive. Several attempts have been made to expand these criteria to include tumors of greater number and size. The model for end-stage liver disease (MELD) prioritization system has utilized the Milan criteria since ad
20#
發(fā)表于 2025-3-24 23:09:01 | 只看該作者
Role of Neoadjuvant and Adjuvant Treatment in HCC Recurrence After Liver Transplantation, the Milan criteria have been shown to be 8–15 % and higher in those patients beyond the Milan criteria. The value of adjuvant therapy using systemic cytotoxic chemotherapy after LT has been disappointing. Sorafenib has been used for treatment in recurrent HCC after LT, and the data of safety and ef
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 19:14
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
涿鹿县| 东丽区| 会昌县| 唐河县| 沛县| 新化县| 沙湾县| 黄平县| 湾仔区| 景宁| 隆林| 黎城县| 扎兰屯市| 鄂托克前旗| 孟津县| 石门县| 汕尾市| 英德市| 赣榆县| 两当县| 全州县| 屏东市| 罗江县| 中牟县| 大港区| 台前县| 聂荣县| 亳州市| 德江县| 怀宁县| 惠来县| 印江| 治县。| 杂多县| 萝北县| 龙泉市| 进贤县| 商河县| 诸城市| 乌审旗| 黄骅市|